Kannalife Sciences was mentioned in an article by Vox written by German Lopez about the use of medical marijuana and the legality of it under federal law.
“The National Institutes of Health (NIH) previously granted an exclusive license to the company KannaLife to develop drugs based on these non-psychoactive compounds for the treatment of brain damage caused by a diseased liver. Before the drugs reach the market, the company will have to conduct clinical trials and obtain Food and Drug Administration (FDA) approval.”
